China Resources Pharmaceutical Group Limited

HKEX:3320.HK

5.35 (HKD) • At close August 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q4
Operating Activities:
Net Income 809.3262,822.631,206.3723,038.061,122.3663,025.0461,330.7832,438.106719.9322,577.194251.0493,035.371,727.9762,249.6271,672.5891,810.4471,185.3411,636.069568.4122,281.6642,767.8642,767.864661.4851,319.759659.879
Depreciation & Amortization 01,764.1611,767.9291,715.6951,549.3351,602.8151,456.8691,365.0211,240.6321,203.4211,240.2621,124.585739.417777.986663.036788.679507.598675.311677.941589.529540.878540.878338.201597.849298.924
Deferred Income Tax 000-16,295.9746,097.982-13,813.5633,443.352000000000000000000
Stock Based Compensation 34.51849.29475.24980.963101.78501.434000000000000000000
Change In Working Capital 13,377.326-10,303.53413,722.868-13,283.1889,973.623-10,908.4218,299.831-7,999.5132,647.567-6,410.0647,715.428-9,727.2614,689.306-8,030.4992,885.06-8,145.567-6,975.535-6,267.5031,077.302-7,453.691-1,454.901-1,454.901-909.722-1,849.485-924.743
Accounts Receivables 0-16,173.22712,482.797-19,352.7577,428.82-15,451.566,658.26-11,855.891-1,572.237-3,548.4594,823.812-12,410.7543,442.343-6,813.022,285.668-6,799.921-3,364.083-5,372.4381,837.557-8,056.346-2,973.301-2,973.301000
Change In Inventory 0-5,582.0381,511.282-4,452.823-1,854.458-781.198-945.874-2,464.8381,487.925-2,293.472356.929-894.4031,246.963-1,217.479599.392-1,345.646-3,611.452-895.065-760.255602.655-1,512.733-1,512.733-945.884-547.503-273.751
Change In Accounts Payables 010,931.316011,021.9593,727.6225,635.695646.1386,890.412,876.621-1,335.5952,358.7393,830.86000000-88.172513.7500000
Other Working Capital 13,377.326520.415-271.212-499.567671.639-311.3581,941.307-569.194-144.742767.462175.948-252.964000000003,031.1333,031.13336.161-1,301.983-650.991
Other Non Cash Items 5,247.4473,756.0734,615.85119,245.693-3,581.41215,714.741-1,218.63312,263.5472,028.92411,542.893-4,104.10412,383.2394,439.941,653.2124,513.989669.3058,790.6714,567.6953,159.8835,087.75-179.905-179.905956.7171,982.957991.478
Operating Cash Flow 19,468.618-1,911.37621,388.269-5,498.75115,267.226-4,368.51213,313.636-2,093.26,948.1-670.92410,161.591-4,907.53411,596.639-3,349.6749,734.674-4,877.1363,508.075611.5725,483.538505.2521,673.9361,673.9361,046.6812,051.0791,025.539
Investing Activities:
Investments In Property Plant And Equipment 0-1,340.941-1,499.152-1,417.324-1,727.013-1,629.312-1,958.011-944.856-1,431.071-787.428-1,219.803-820.709-635.262-881.384-408.305-1,158.407-1,053.257-665.177-1,391.77-431.419-1,142.031-1,142.031-0.5974.6472.324
Acquisitions Net 01,977.583-1,035.51,402.475-1,369.215797.059-930.079-81.001-227.001144.047-251.3381,286.283000000-707.837186.245-407.129-407.129000
Purchases Of Investments 0-71.5380-8,986.88512,914.815-15,962.36612,175.693-13,269.46325,865.285-26,236.73320,729.771-22,332.871000000-3,878.251-4,156.51-6,020.631-6,020.631-3,764.587-2,160.712-1,080.356
Sales Maturities Of Investments 015,826.622010,826.071-15,349.25515,365.589-11,802.57511,802.912-22,727.79823,264.24-22,416.3522,546.5760000004,586.0883,970.2654,377.8594,377.8592,737.3931,462.585731.293
Other Investing Activites 0-18,634.028-44.55553.7253,610.93850.374-3,840.49915.209104.21710.5613,506.73813.522-7,186.061-1,098.295-3,976.329-2,968.526-472.879238.253-5,146.4582,528.8331.7311.7311,027.791693.48346.74
Investing Cash Flow 0-2,242.302-2,579.2071,878.062-1,919.73-1,378.656-6,355.471-2,477.1991,583.632-3,605.313349.018692.801-7,821.323-1,979.679-4,384.634-4,126.933-1,526.136-426.924-5,830.3911,911.169-3,190.2-3,190.2-1,086.092301.537150.769
Financing Activities:
Debt Repayment 05,859.29800-14,060.0669,004.46-4,690.2070-9,994.1766,598.19300000000002,591.6652,591.665000
Common Stock Issued 00003,358.440-370.90102,820.720000000003,765.31200002,641.0071,320.504
Common Stock Repurchased 0-82.21700-150.705-332.739-86.761020.941-166.376000000000000000
Dividends Paid 00-968.0810-942.3770-0-753.902-691.0760-0-816.986-0.011-691.286-0.009-565.597000000000
Other Financing Activities 0-4,501.565-15,100.05612,747.542-4,893.837-2,078.649-1,032.01611,875.9781,332.716-1,689.783-11,455.5663,169.2981,731.4483,627.292-5,759.819,452.2871,902.037-2,527.495888-2,442.283-1,356.096-1,356.096-9,621.278-11,794.783-5,897.391
Financing Cash Flow 01,275.516-16,068.13612,747.542-16,688.5457,686.944-5,808.98411,122.076-9,331.5955,730.41-11,455.5662,352.3121,731.4372,936.006-5,759.8198,886.691,902.037-2,527.495888-2,442.2831,235.5691,235.569-9,621.278-11,794.783-5,897.391
Other Information:
Effect Of Forex Changes On Cash 06.171750.6-741.002840.431-803.426-625.698263.009-1,133.489279.682-223.362-4.712-530.945-120.858283.272446.368-406.309-377.514-1,048.51912.236-294.823-294.8239,300.82910,683.0485,341.524
Net Change In Cash -23,953.412-2,311.3193,491.5268,276.253-1,839.865630.1671,162.7916,441.547-544.6881,129.488-1,056.072-1,867.1334,975.808-2,514.205-126.507328.9893,477.667-2,720.361-10,229.25510,288.3320-15,175.387-359.861620.441620.441
Cash At End Of Period 030,083.00127,423.18432,394.3224,118.06725,957.93225,327.76524,164.97417,723.42718,268.11517,138.62718,194.69916,636.33711,660.52914,174.73414,301.24113,972.25210,494.5853,493.06313,722.31810,983.81503,433.9863,793.8473,793.847